How to Buy Hims & Hers Health Stock
Hims & Hers Health Inc
Hims, Inc. manufactures men's wellness products. It offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products.
Hims & Hers Health stock last closed at $46.02, down 2.36% from the previous day, and has increased 192.93% in one year. It has overperformed other stocks in the Household & Personal Products industry by 2.13 percentage points. Hims & Hers Health stock is currently +241.65% from its 52-week low of $13.47, and -36.94% from its 52-week high of $72.98.
As of Aug 15, 2025, there are 226.02M shares of HIMS outstanding. The market value of HIMS is $10.40B. In the last 24 hours, 18.08M HIMS shares were traded.
How to Buy Hims & Hers Health Stock
Not sure how to invest in Hims & Hers Health stock? Here's how.
- Figure out where to buy Hims & Hers Health stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Hims & Hers Health stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Pick your method of payment and add your details.
- Evaluate Hims & Hers Health stock: The Hims & Hers Health ticker symbol is HIMS. Is Hims & Hers Health stock a good investment? Should you buy shares of HIMS? How do HIMS's underlying business fundamentals look? Do top analysts think Hims & Hers Health is a good buy? Why has HIMS's stock price moved recently? (Hint: Our stock analysis website can help you decide if HIMS is a good stock to buy).
- Place your HIMS trade: Decide if you will purchase HIMS shares at the current market price or use a limit order to purchase HIMS stock at a given price.
- Get notifications regarding your HIMS position: Create a watchlist to get live updates on your investment in Hims & Hers Health stock.
Step 1: Figure out where to buy Hims & Hers Health stock
You need an online brokerage account in order to access the NYSE market and buy HIMS shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Technology to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, it's time to fill out some personal information so you can invest in HIMS today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new brokerage account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have opened your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch this video walkthrough to see the process of transferring funds into your new brokerage account.
Step 4: Evaluate Hims & Hers Health stock
Once you have figured out the best place to buy Hims & Hers Health stock, it's absolutely critical to analyze their stock before you buy, so you actually understand the risk and opportunity.
Hims & Hers Health stock at a glance
Fundamentals of Hims & Hers Health
WallStreetZen was built to help part-time investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on HIMS's stock page.
Is HIMS stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge HIMS's fair value.
Using relative valuations methods:
- HIMS may be overvalued based on its P/E ratio of 52.9x, relative to Household & Personal Products industry P/E ratio of 21.49x
- HIMS may be overvalued based on its P/B ratio of 18.48x, relative to Household & Personal Products industry P/B ratio of 7.04x
- HIMS may be overvalued based on its PEG ratio of 4.45x
You can access more valuation research on HIMS's stock here.
HIMS Financial Overview
Positive Health Checks:
- HIMS's operating cash flow of $261.63M allows it to safely service it's debt of $1.04B.
- There are more short-term assets than long-term liabilities on the HIMS balance sheet.
- HIMS profit margin has gone up from 1.7% to 9.6% in the past year.
- There are more short-term assets than short-term liabilities on the HIMS balance sheet.
- HIMS earnings of $139.23M is not enough to cover its interest payments.
Negative Health Checks:
- HIMS has a relatively high debt to equity ratio of 2.34.
- Total HIMS debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy HIMS stock
Out of 9 Wall Street analysts who track HIMS, the consensus analyst rating on Hims & Hers Health is a Hold
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Latest HIMS Analyst Recommendations
Allen Lutz, a bottom 14% analyst from Bank of America maintains HIMS with a sell rating and raises their HIMS price target from $22.00 to $26.00, on Apr 29, 2025.
Jonna Kim, a top 33% analyst from TD Cowen downgrades HIMS to a hold rating and lowers their HIMS price target from $44.00 to $30.00, on Apr 29, 2025.
Michael Cherny, a top 15% analyst from Leerink Partners maintains HIMS with a hold rating and raises their HIMS price target from $24.00 to $40.00, on Feb 25, 2025.
Leerink Partners's Michael Cherny raised their price target on Hims & Hers Health (NYSE: HIMS) by 66.7% from $24 to $40 on 2025/02/25. The analyst maintained their Hold rating on the stock.
Hims & Hers Health reported its Q4 and FY 2024 earnings.
Looking ahead, Cherny highlighted that "with the semaglutide shortage effectively over, Hims & Hers Health should be able to drive fundamental price discovery based on its underlying growth more than broad-based speculation."
However, the analyst cautioned that contrary to management's "headline guidance calling for ongoing robust growth," Leerink Partners believes the company's "growth vectors have some ongoing questions."
Earnings Report
Hims & Hers Health reported:
For Q4 2024:
- EPS of $0.11, which missed the Zacks Consensus Estimate of $0.12 but beat Q4 2023's $0.01.
- Revenue of $481.1M, which beat the Zacks Consensus Estimate by 2.1% and was up 95.1% Y/Y.
For FY 2024:
- EPS of $0.53, which missed the Zacks Consensus Estimate by 3.6% but beat FY 2023's $(0.11).
- Revenue of $1.48B, which beat the Zacks Consensus Estimate by 0.7% and was up 69.3% Y/Y.
Management guided:
For Q1 2025:
- Revenue of $520M to $540M.
For FY 2025:
- Revenue of $2.3B to $2.4B, representing 56% to 63% Y/Y growth.
CEO Andrew Dudum commented: “2024 was a fantastic year at Hims and Hers as we continue to build a platform that leverages personalization and technology unlike any traditional healthcare system.
“Over 2 million subscribers now entrust Hims & Hers to aid them in their journey to better health - with thousands more joining daily.
"In the coming years, we expect to further transform how individuals can improve their health with more comprehensive treatments, technologies that normalize unlimited follow-up support, and tools that can eventually be exported beyond Hims and Hers, enabling even more Americans to access this care.
"We believe an ongoing focus in these areas will allow every household in the country to access high quality, precision care that is convenient and affordable and expect 2025 will be another exciting step toward our vision of this next-generation of healthcare.”
Maria Ripps, a top 9% analyst from Canaccord Genuity maintains HIMS with a strong buy rating and raises their HIMS price target from $38.00 to $68.00, on Feb 19, 2025.
You can dive deeper into what analysts are projecting on the Hims & Hers Health stock forecast page.
HIMS Trading Indicators
HIMS Revenue
Last year, HIMS earnings were $193.60M. Over the past one years, HIMS's earnings have gone up by 987.5% per year. This was faster than the Household & Personal Products industry average of 15.78%.
Last year, HIMS revenue was $2.01B. In the past five year, HIMS's revenue has grown by 68.43% per year. This was faster than the Household & Personal Products industry average of 4.35%.
Dive into HIMS's earnings and revenue performance here.
Are HIMS executives and large shareholders buying or selling the stock?
In the last 12 months, executives and large shareholders at HIMS have sold more shares than they have bought.
Oluyemi Okupe, Chief Financial Officer of HIMS, was the latest HIMS insider to buy. They bought $58,020.81 worth of HIMS shares on Aug 13, 2025.
Research more about who owns HIMS shares here.
Does HIMS stock generate passive income?
No, Hims & Hers Health doesn't provide an income stream by paying out dividends.
What others are saying about HIMS
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your HIMS trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open button and eToro will execute the order.
If you want more help with investing in stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your HIMS position
Now that you own some HIMS stock, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your HIMS stock.
HIMS Feed
How to Buy Stock in Hims & Hers Health
To reiterate, here are the 6 steps to buy stock in Hims & Hers Health:
- Figure out where to buy Hims & Hers Health stock
- Create a brokerage account
- Fund your investment account
- Evaluate Hims & Hers Health stock
- Place your HIMS trade
- Get notifications regarding your HIMS position
If you require a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to monitor your new investment in Hims & Hers Health, create a watchlist on WallStreetZen today.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.